Skip to main content
. 2022 Apr 25;10(5):991. doi: 10.3390/biomedicines10050991

Table 1.

Inclusion and exclusion criteria.

Inclusion Criteria
  • -

    Diagnosis of OA changes stage II-III Kellgren–Lawrence by radiography (postural bilateral lower limb, weight-bearing standard knee anterior-posterior view in full extension, lateral view in 30 of flexion).

  • -

    No prior PRP injection in the knee.

  • -

    No prior surgical procedure in participating knee.

  • -

    Unilateral Visual Analog Scale (VAS) pain score 4–9 for >6 months.

  • -

    Age between 40 and 75 years.

  • -

    BMI < 40 kg/m2

  • -

    Ability to provide informed consent.

  • -

    Conservative treatment in the form of exercise, weight reduction, and physical therapy for at least 6 months, without improving the function and reducing pain.

  • -

    The patient will refrain from treating the knee joints by intra-articular injection, surgery, and physical therapy for the duration of the study.

  • -

    The patient refrains from taking pain relievers, including non-steroidal anti-inflammatory drugs (NSAIDs), for the duration of the study. Only paracetamol preparations are allowed on an ad hoc basis with a ban on taking them 24 h before the visit.

Exclusion Criteria
  • -

    Type II diabetes.

  • -

    Fibromyalgia.

  • -

    Anemia.

  • -

    Coagulation disorders or taking anticoagulants.

  • -

    Pregnancy or lactation.

  • -

    Allergic to a steroid drug or hyaluronic acid.

  • -

    Large (more than 10 mL of aspirated synovial fluid) effusion in the knee joint or abnormal synovial fluid appearance.

  • -

    A history of purulent inflammation of the knee.

  • -

    Rheumatic diseases and systemic diseases of connective tissue.

  • -

    Active neoplastic disease.

  • -

    The patient is undergoing oral steroid therapy, antibiotic therapy or biological treatment.

  • -

    The patient received an intra-articular injection into the examined joint in less than a year before the screening visit.

  • -

    The patient had previous operations, fractures, ligaments or meniscus injuries in the area of the examined lower limb.

  • -

    The patient has a Baker’s cyst.

  • -

    The patient is addicted to nicotine, alcohol, or drugs.

  • -

    The patient had an injury to the examined knee joint within one month of the screening visit.

  • -

    The patient has a significant deformation of the examined knee joint.

  • -

    There is a valgus or varus greater than 10° in any of the knees.

  • -

    The range of motion of the knee joint is less than 100°.

  • -

    Major axial deviation (varus > 5, valgus > 5).

  • -

    Any concomitant symptomatic knee disorder (i.e., ligamentous or meniscal injury).

  • -

    Hematologic disease.

  • -

    Active infection.

  • -

    Recent intra-articular injection of corticosteroid or HA in past 6 months.